Sapience Therapeutics, Inc.’s Post

Today is Day 3 of the Biotechnology Innovation Organization International Convention. This is where business and breakthroughs converge in Biotech and Life Sciences. You don't want to miss out on this one, come see us! #BIO2024 #futureofhealthcare #BIO #clinicaltrials

Our latest Life Sciences and Capital Markets & Securities client alert by Lowenstein’s Jim Shehan and Daniel Porco explores the implications of proposed legislation called the BIOSECURE Act on the biotech industry and sheds light on the critical steps companies can take to prepare for its passage. Read the full alert: https://bit.ly/3PpEwMB #lifesciences #biotechnology #biosecureact #biotechindustry #lawyers

Let’s continue to drive innovation and collaboration in biotechnology. Every idea and discovery shared at this conference contributes to a brighter future. A heartfelt thank you to all the speakers, participants, and supporters for making this event a success. We look forward to seeing everyone at our next gathering! #biotechnology #upm #weloveupm #conference2024 #biotechhorizon2024 #biotechhorizon #innovation #withknowledgeweserve

At the 2024 ISPE Biotechnology Conference, track 2 will serve as a platform for exploring “Quality Culture within the Quality Management Maturity (QMM) Framework” within the industry and the ways regulators envision a future in which quality is not just a compliance requirement, but a driver for more reliable supply of safe and effective drugs for patients, instilled across all facets of daily operations. Read more about why you don't want to miss out on this conference: https://hubs.la/Q02tXmvM0 #ISPE #ISPEBiotech #biotech #biotechnology

How did Eli Lilly outperform its biotech peers? Our new blog discusses Prospero.ai’s prediction of LLY's success, highlighting the crucial balance of innovation and profitability Read the full post here: https://lnkd.in/dnfrvxfi #Biotechnology #InvestmentTrends

According to a recent industry survey, 80% of pharma and biotech companies find the one-stop shop model of large global CROs is no longer cost-effective. Concerns about stability, project disruptions, and poor service delivery are driving a shift towards more agile, midsize organisations. 📚 Learn more about this trend: https://lnkd.in/eq5eddcv #PharmaTrends #ClinicalResearch #CROs #Biotechnology #ServiceDelivery #PharmaSols

Curious about the truths behind biotechnology? We’re diving into three common myths that need debunking! 👉 Read on to discover the facts and join the conversation! #Biotech #Innovation #MythBusting #Pharma

So excited to speak at #BIO2024 about the impact of the #inflationreductionact #ira in #raredisease #drugdevelopment today!

SFBN Feed: Guest opinion: Don’t break the life-sciences industry https://lnkd.in/gfxDEc4D Moves by Congress and the Biden administration are weakening incentives to bring lifesaving drugs to market. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #BayArea #SanFrancisco #Biotech #Lifescience #News

Are you a U.S. company considering collaborations with Chinese biotech companies? Find out how the proposed BioSecure Act may influence your strategic planning in Lowenstein Sandler LLP's recent client alert. #lifesciences #biotechnology #biosecureact #biotechindustry #lawyers